6.63% -0.205

Evoke Pharma Inc (EVOK)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Evoke Pharma Inc Stock (EVOK) Company Profile

Evoke Pharma Inc

Healthcare (1171)

858-345-1494

420 STEVENS AVENUE, SOLANA BEACH, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

EVOK's Discussions on Twitter

Vergleichen Sie EVOK mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EVOK Evoke Pharma Inc	3.65	5.56M	8.62M	-6.15M	-5.32M	-11.03
ZTS Zoetis Inc	159.75	71.40B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.03	47.36B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.14	46.03B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.46	18.86B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.28	13.96B	612.78M	-86.37M	-62.91M	-0.87

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-06-22	Hochstufung	H.C. Wainwright	Neutral → Buy
2019-03-05	Herabstufung	H.C. Wainwright	Buy → Neutral
2018-03-08	Bestätigt	B. Riley FBR, Inc.	Buy
2017-10-19	Fortgesetzt	FBR & Co.	Buy
2017-03-16	Bestätigt	Rodman & Renshaw	Buy
2017-01-30	Hochstufung	Laidlaw	Neutral → Buy
2017-01-05	Hochstufung	Rodman & Renshaw	Neutral → Buy
2016-12-23	Bestätigt	Rodman & Renshaw	Neutral
2016-07-19	Bestätigt	FBR Capital	Outperform
2016-07-19	Herabstufung	Noble Financial	Buy → Hold
2016-07-18	Herabstufung	Rodman & Renshaw	Buy → Neutral
2016-03-16	Eingeleitet	Northland Capital	Outperform
2016-03-14	Bestätigt	Ascendiant Capital Markets	Buy
2016-02-17	Fortgesetzt	FBR Capital	Outperform
2014-12-03	Bestätigt	MLV & Co	Buy
2014-11-07	Eingeleitet	MLV & Co	Buy
2014-04-22	Eingeleitet	Laidlaw	Buy
2013-11-19	Eingeleitet	Aegis Capital	Buy

Alle ansehen

Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten

Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)

Evoke Pharma Inc (EVOK)

Evoke Pharma Inc Stock (EVOK) Company Profile

Vergleichen Sie EVOK mit anderen Aktien

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten

Evoke Pharma Inc (EVOK) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans - Yahoo Canada Finance

Evoke Pharma Reports Strong Revenue Growth in 2024 - TipRanks

Earnings call transcript: Evoke Pharma Q4 2024 reports strong sales growth - Investing.com

Evoke Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Marketscreener.com

EVOKE PHARMA Earnings Results: $EVOK Reports Quarterly Earnings - Nasdaq

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

The Canada Foundation for Innovation supports Canada Research Chairs with nearly $4.4 million investment in research infrastructure - The Manila Times

Earnings Scheduled For March 13, 2025 - Benzinga

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Gastroparesis Treatment Market Poised for Substantial Growth - openPR

Evoke Pharma to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025 - GlobeNewswire

Evoke Pharma, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025 - Nasdaq

When Will Evoke Pharma Share Its Latest Gimoti Sales Numbers? - StockTitan

Evoke Pharma (EVOK) to Release Quarterly Earnings on Wednesday - Defense World

Sanctuary Advisors LLC Sells 40,570 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK) - Defense World

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Shares Sold by Sanctuary Advisors LLC - Defense World

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sanctuary Advisors LLC - Defense World

Evoke Pharma (NASDAQ:EVOK) Stock Crosses Below 200 Day Moving Average – Should You Sell? - Defense World

Alliance Bioenergy Plus (OTCMKTS:ALLM) Shares Cross Below 200 Day Moving Average – Time to Sell? - Defense World

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World

Evoke Pharma stock hits 52-week low at $3.49 amid challenges - Investing.com India

Evoke Pharma stock hits 52-week low at $3.49 amid challenges By Investing.com - Investing.com South Africa

Evoke Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Investor Network: Evoke Pharma, Inc. to Host Earnings Call - ACCESS Newswire

Gastroparesis Drugs Market Forecast: Insights, Trends & Key - openPR

Diabetic Gastroparesis Treatment Market Future Business - openPR

Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com - Armenian Reporter

Evoke Pharma adds pharma veteran to its board - Investing.com

Evoke Pharma adds pharma veteran to its board By Investing.com - Investing.com South Africa

Evoke Pharma appoints new director Greg Pyszcymuka - Investing.com

5 Top AI Stocks I'm Buying on the Dip - The Globe and Mail

Evoke Pharma appoints new director Greg Pyszcymuka By Investing.com - Investing.com South Africa

Evoke Pharma, Inc. Appoints Greg Pyszczymuka to Board of Directors, Strengthening Commercial Strategy - Nasdaq

Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors - GlobeNewswire

Can This New Board Member Transform Evoke Pharma's Commercial Success? - StockTitan

(EVOK) Investment Analysis and Advice - Stock Traders Daily

Geriatric Medicines Market Poised for Significant Expansion | - openPR

Gastric Motility Disorder Drug Market Witnessing High Demand | - openPR

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com - Defense World

Gastroparesis Drugs Market: $6,662.35 Million by 2032, 4.4% CAGR - openPR

Gastroparesis Treatment Market Generated Opportunities, - openPR

Evoke Pharma (NASDAQ:EVOK) Now Covered by StockNews.com - Defense World

Loss-Making Evoke Pharma, Inc. (NASDAQ:EVOK) Set To Breakeven - Simply Wall St

Research Analysts’ New Coverage for February 8th (AC, APT, ARL, BIOL, CCRN, CNET, EDAP, ENLC, ENSV, ESGR) - Armenian Reporter

Gastroparesis Market Expected to rise, 2034 | Vanda - openPR

Nantahala Capital Management, LLC Increases Stake in Evoke Pharm - GuruFocus.com

Evoke Pharma (NASDAQ:EVOK) Stock Crosses Below 200 Day Moving Average – Here’s What Happened - Defense World

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Nantahala Capital Management, LLC Reduces Stake in Evoke Pharma Inc - GuruFocus.com

Trane Technologies (TT) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

VF Corp (VFC) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail

Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie EVOK